Mycobacterium avium complex (MAC) disease, a relatively common opportunistic infection in patients with AIDS, is usually treated with a macrolide-based combination regimen. A macrolide or ...

The Company also initiated a full review of the Phase 2 data and an assessment of pathways for continued development in TR-MAC. Ninety-seven subjects completed treatment in Phase 3, the data for ...

“Initiating this pivotal Phase 2/3 trial marks an important step towards delivering a new treatment option to patients with treatment-refractory MAC lung disease, an area which has seen little ...

it also follows the precedent established by Insmed’s confirmatory study of Arikayce in treatment-naïve MAC patients, where the same QOL-B instrument has been reported as the primary efficacy ...